Anne-Marie Carbonell
Overview
    Explore the profile of Anne-Marie Carbonell including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              3
            
            
              Citations
              37
            
            
              Followers
              0
            
  
  Related Specialty
          Related Specialty
  Co-Authors
          Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Nwagwu C, Immidisetti A, Jiang M, Adeagbo O, Adamson D, Carbonell A
  
  
    Pharmaceutics
    . 2021 Apr;
          13(4).
    
    PMID: 33921157
  
  
          Development of effective treatments for high-grade glioma (HGG) is hampered by (1) the blood-brain barrier (BBB), (2) an infiltrative growth pattern, (3) rapid development of therapeutic resistance, and, in many...
      
2.
        
    Clinically Explored Virus-Based Therapies for the Treatment of Recurrent High-Grade Glioma in Adults
  
  
    
    Immidisetti A, Nwagwu C, Adamson D, Patel N, Carbonell A
  
  
    Biomedicines
    . 2021 Feb;
          9(2).
    
    PMID: 33535555
  
  
          As new treatment modalities are being explored in neuro-oncology, viruses are emerging as a promising class of therapeutics. Virotherapy consists of the introduction of either wild-type or engineered viruses to...
      
3.
        
    
    Nwagwu C, Immidisetti A, Bukanowska G, Vogelbaum M, Carbonell A
  
  
    Pharmaceutics
    . 2021 Jan;
          13(1).
    
    PMID: 33396712
  
  
          Introduction: OS2966 is a first-in-class, humanized and de-immunized monoclonal antibody which targets the adhesion receptor subunit, CD29/β1 integrin. CD29 expression is highly upregulated in glioblastoma and has been shown to...